Moreover, both IL-4 and IL-13 contribute to the increased production of reactive reactive oxygen species (ROS) in CRC, which, in turn, contributes to the development of inflammation-mediated malignancies [112,113]. This evidence concerns the gene IL13 and colorectal carcinoma.